Ann: Imagion establishes collaboration with Siemens Healthineers, page-18

So we not only have the Israelis buying our nano particles for their thermal hunter killer treatment development, but now also the potential as a contrasting agent for a 74 BILLION dollar MC company.....

So when thinking valuation, its not just about how big our imagining early detection can be, proven pre clinical in animals, and that next step into human trials, to set us among the big boys of blue sky if we are successful,

BUT, also the revenue streams of our sales of nano particles.

In valuation terms, its not all on risk of our human trials, but diversified with income streams of those using our nano particles.

Plenty of other med tech, hit that 100m mc non commercial, like IMU, BIT, etc and we are a yard in front, with third parties validating their interest in our tech.